

…
YORIAI means people gathering and meeting. In Japanese villages from the Middle Ages onwards, YORIAI was a place for people to collaborate and make various discussions and arrangements to enrich their lives in village together. This is where the name YORIAILab comes from.
YORIAILab is a place where patient groups, advocates, and people from industry, government, and academia involved in the development and provision of pharmaceuticals can gather and connect across borders to think about and create various collaborations. We will bring together a wide range of knowledge and experience to work on social co-creation in healthcare. We will create an environment where as many people living with illnesses as possible can continue to develop their strengths.
YORIAILab is a 'community lab' where, together with Clinical Trial Ambassadors, we engage in mutual learning and exchange regarding drug development, collaborate and conduct research to resolve problems from the patient's perspective, and give back to society the knowledge gained through public relations and publishing, as well as promote and support patient and public involvement (PPI) in the healthcare and medicine, and provide consultations.
News
Our first symposium will be held to discuss the topic of patient online communities.

🎞️"Patient Experience Data" video
The recording of the 1st Lunchtime Short Seminar (October/November 2024) has been made available to the public on YouTube➡️ (there are two recordings with the content roughly the same).
🌐 May 20th is International Clinical Trials Day
We are planning three events to commemorate this day. First, on May 16th, we will hold a session on the Clinical Trial Ambassador project at an online awareness event hosted by the Pharmaceutical Research and Manufacturers of America (PhRMA). After introducing to the project, clinical trial ambassadors will share their experiences in the project, followed by a panel discussion.

Shirakawa-go (Castle Tower Observatory)
( © SHori ( Creative Commons License (Attribution 4.0 International)) )